Suppr超能文献

[卵巢小细胞癌,高钙血症型:临床病理特征分析及SMARCA4蛋白表达缺失的诊断效用]

[Small cell carcinoma of ovary, hypercalcemic type: analysis of clinicopathologic characteristics and the diagnostic utility of loss expression of SMARCA4 protein].

作者信息

Wang Lei, Tan Cong, Tu Xiaoyu, Zhang Yongsheng, Li Xinxia, Chang Bin

机构信息

Department of Pathology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical School, Fudan University, Shanghai 200032, China.

E-mail:

出版信息

Zhonghua Bing Li Xue Za Zhi. 2015 Dec;44(12):859-63.

Abstract

OBJECTIVE

To study the clinicopathologic features of small cell carcinoma of ovary, hypercalcemic type (SCCOHT) and to evaluate the diagnostic significance of loss of SMARCA4 expression.

METHODS

The clinicopathologic characteristics of 5 cases of SCCOHT were reviewed. The expression of SMARCA4 protein was detected by immunohistochemistry in the cases of SCCOHT and 240 cases of other primary malignant tumors of ovary and peritoneum.

RESULTS

The mean and medium age of these patients was 30 years and 28 years, respectively. The presenting symptoms included abdominal pain, distention and a pelvic mass. Hypercalcemia was found in 3 patients. The maximum diameter of tumors ranged from 13.5 to 22.0 cm. Extraovarian spread was demonstrated in all of the patients on presentation. Histologically, the tumors were composed of closely packed small round cells with scanty cytoplasm, hyperchromatic nuclei and irregular chromatin clumps. The tumor cells grew in sheets, nests, cords or trabecular pattern. Follicle-like spaces were observed in 4 cases. Three of the tumors contained large cells with abundant eosinophilic cytoplasm. Spindle cell morphology was found in 1 case. There were 2 cases with myxoid or hyaline stroma. Four out of five of SCCOHT cases showed loss of SMARCA4 protein while only 6.3% (15/240) of the other primary malignant tumors of ovary and peritoneum , including undifferentiated carcinoma (1/5), high-grade serous carcinoma (4.6%, 5/109), endometrioid carcinoma (7.7%, 2/26), clear cell carcinoma (1/9), mucinous carcinoma (1/5), mixed carcinoma (4.9%, 3/61), carcinosarcoma (1/9) and high-grade serous carcinoma of peritoneum (1/9), were negative.

CONCLUSIONS

SCCOHT is a rare malignant tumor and often misdiagnosed as other types of ovarian small cell tumor. Loss expression of SMARCA4 protein is characteristic and facilitates the diagnosis and differential diagnosis of SCCOHT.

摘要

目的

研究高钙血症型卵巢小细胞癌(SCCOHT)的临床病理特征,并评估SMARCA4表达缺失的诊断意义。

方法

回顾5例SCCOHT的临床病理特征。采用免疫组织化学法检测SCCOHT病例及240例其他卵巢和腹膜原发性恶性肿瘤中SMARCA4蛋白的表达。

结果

这些患者的平均年龄和中位年龄分别为30岁和28岁。主要症状包括腹痛、腹胀和盆腔肿块。3例患者出现高钙血症。肿瘤最大直径为13.5至22.0 cm。所有患者初诊时均有卵巢外扩散。组织学上,肿瘤由紧密排列的小圆形细胞组成,细胞质稀少,核深染,染色质团块不规则。肿瘤细胞呈片状、巢状、条索状或小梁状生长。4例可见滤泡样间隙。3例肿瘤含有胞质丰富的大细胞。1例呈梭形细胞形态。2例有黏液样或透明样间质。5例SCCOHT病例中有4例显示SMARCA4蛋白缺失,而其他卵巢和腹膜原发性恶性肿瘤中只有6.3%(15/240)为阴性,包括未分化癌(1/5)、高级别浆液性癌(4.6%,5/109)、子宫内膜样癌(7.7%,2/26)、透明细胞癌(1/9)、黏液性癌(1/5)、混合性癌(4.9%,3/61)、癌肉瘤(1/9)和腹膜高级别浆液性癌(1/9)。

结论

SCCOHT是一种罕见的恶性肿瘤,常被误诊为其他类型的卵巢小细胞肿瘤。SMARCA4蛋白表达缺失是其特征,有助于SCCOHT的诊断和鉴别诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验